aod9604 clinical trials efficacy fat loss AOD 9604: The Ultimate Guide to Loss, Tissue Repair, and Metabolic Health AOD-9604: The Fat-Loss Peptide —

The peptide was developed in the late 1990s and early 2000s with the explicit goal of separating the fat-mobilising activity of growth hormone from its other physiological effects, particularly its effects on IGF-1 production and insulin sensitivity

More research is needed to understand the relationship between homocysteine levels, vitamin B12 and cognitive function

May help overcome weight loss plateaus when paired with a healthy lifestyle

IM injections allow for slow absorption into the blood, providing a longer-lasting effect

Reduction of Abdominal and Visceral Fat : Animal and early human models have demonstrated a preferential reduction of abdominal fat following subcutaneous administration of AOD-9604

Key Insight: With no energy improvements by week 4, bloodwork can help assess whether NNMT is being effectively inhibited